Clinical Trial Update: PK Profile and Preliminary Efficacy of TNP-2092 Capsules in Liver Cirrhosis Patients With Hyperammonemia [Phase 1, Phase 2]

View source ↗

Summary

The update reports the pharmacokinetic profile and preliminary efficacy signals of the investigational drug TNP-2092 in patients with liver cirrhosis and hypera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperammonemia
• Liver Cirrhosis

Drugs mentioned

• TNP-2092

Snippet

Sponsor: TenNor Therapeutics (Suzhou) Limited | Conditions: Hyperammonemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-05-10